Moving beyond the national lung screening trial: Discussing strategies for implementation of lung cancer screening programs

Oncologist

Volumn 18, Issue 8, 2013, Pages 941-946

  Goulart, Bernardo H L ^a,b   Ramsey, Scott D ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Implementation; Low Dose CT; Lung cancer; Screening

Indexed keywords

ARTICLE; CANCER MORTALITY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; FALSE POSITIVE RESULT; FOLLOW UP; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; LUNG CANCER; POSITRON EMISSION TOMOGRAPHY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING; SYSTEMATIC REVIEW (TOPIC); THORAX RADIOGRAPHY;

IMPLEMENTATION; LOW-DOSE CT; LUNG CANCER; SCREENING;

CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; PROSPECTIVE STUDIES; RADIATION DOSAGE; RISK FACTORS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84883222232     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0007     Document Type: Article

References (45)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Robinson BM, Kennedy C, McLean J et al. Nodenegative non-small cell lung cancer: Pathological staging and survival in 1765 consecutive cases. J Thorac Oncol 2011;6:1691-1696.
3. Patz EF Jr., Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000;343:1627-1633.
4. Patz EF Jr., Rossi S, Harpole DH Jr. et al. Correlation of tumor size and survival in patients with pathologic stage lA nonsmall cell lung cancer. Chest 2000;117:1568-1571.
5. Brett GZ. The value of lung cancer detection by six-monthly chest radiographs. Thorax 1968;23: 414-420.
6. Weiss W, Boucot KR. The Philadelphia Pulmonary Neoplasm Research Project. Early roentgenographic appearance of bronchogenic carcinoma. Arch Intern Med 1974;134:306-311.
7. Berlin NI, Buncher CR, Fontana RS et al. The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence) Early lung cancer detection: Introduction Am Rev Respir Dis 1984;130:545-549.
8. Flehinger BJ, Melamed MR, Zaman MB et al. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 1984;130:555-560.
9. Fontana RS, Sanderson DR, Taylor WF et al. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 1984;130: 561-565.
10. Frost JK, Ball WC Jr., Levin ML et al. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984;130:549-554.
11. Morrison AS. The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening. Int J Epidemiol 1982;11:261-267.
12. Patz EF Jr. Lung cancer screening, overdiagnosis bias, and reevaluation of the Mayo Lung Project. J Natl Cancer Inst 2006;98:724-725.
13. Oken MM, Hocking WG, Kvale PA et al. Screening by chest radiograph and lung cancer mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial JAMA 2011;306:1865-1873.
14. Marcus PM, Bergstralh EJ, Fagerstrom RM et al. Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up. J Natl Cancer Inst 2000;92:1308-1316.
15. Kubik AK, Parkin DM, Zatloukal P. Czech Study on Lung Cancer Screening: Post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer 2000;89:2363-2368.
16. Hocking WG, Hu P, Oken MM et al. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial J Natl Cancer Inst 2010;102:722-731.
17. Aberle DR, Adams AM, Berg CD et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
18. Bach PB, Mirkin JN, Oliver TK et al. Benefitsand harms of CT screening for lung cancer: A systematic review. JAMA 2012;307:2418-2429.
19. Saghir Z, Dirksen A, Ashraf H et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: Status after five annual screening rounds with lowdose CT Thorax 2012;67:296-301.
20. Infante M, Cavuto S, Lutman FR et al. A randomized study of lung cancer screening with spiral computed tomography: Three-year results from the DANTE trial. Am J Respir Crit Care Med 2009; 180:445-453.
21. van den Bergh KA, Essink-Bot ML, Borsboom GJ et al. Long-term effects of lung cancer computed tomography screening on health-related quality of life: The NELSON trial. Eur Respir J 2011;38:154-161.
22. Draisma G, Etzioni R, Tsodikov A et al. Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context. J Natl Cancer Inst 2009;101:374-383.
23. Reich JM. A critical appraisal of overdiagnosis: Estimates of its magnitude and implications for lung cancer screening. Thorax 2008;63:377-783.
24. Pyenson BS, Sander MS, Jiang Y et al. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood) 2012; 31:770-779.
25. Goodman A. Screening with low-dose helical CT scans cuts lung cancer deaths in heavy smokers. Oncology Business Review. Available at http:// www.oncbiz.com/blog/2010/11/screening-withlow-dose-helical-ct-scans-cuts-lung-cancer-deathsin-heavy-smokers/. Accessed June 24, 2013.
26. Arenberg D, Kazerooni EA. Setting up a lung cancer screening program. J Natl Compr Canc Netw 2012;10:277-285.
27. Aberle DR, Henschke CI, McLoud TC et al. Expert opinion: Barriers to CT screening for lung cancer. J Thorac Imaging 2012;27:208.
28. Ravenel JG. Lung cancer screening: Confession of a skeptic. J Thorac Imaging 2012;27:207.
29. Leventhal W. Primary care perspectiveonlung cancer screening. J Thorac Imaging 2012;27:209-210.
30. Centers for Disease Control. Current smoking. Available at http://www.cdc.gov/nchs/data/nhis/ earlyrelease/201106_08.pdf. Accessed June 24, 2013.
31. Ma J, Ward EM, Smith R et al. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer 2013;119: 1381-1385.
32. Goulart BH, Bensink ME, Mummy DG et al. Lung cancer screening with low-dose computed tomography: Costs, national expenditures, and costeffectiveness. J Natl Compr Canc Netw 2012;10: 267-275.
33. Chirikos TN, Hazelton T, Tockman M et al. Screening for lung cancer with CT: A preliminary cost-effectiveness analysis. Chest 2002;121:1507-1514.
34. Mahadevia PJ, Fleisher LA, Fric KD et al. Lung cancer screening with helical computed tomography in older adult smokers: A decision and cost-effectiveness analysis. JAMA 2003;289: 313-322.
35. Marshall D, Simpson KN, Earle CC et al. Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer 2001;32:227-236.
36. Wisnivesky JP, Mushlin AI, Sicherman N et al. The cost-effectiveness of low-dose CT screening for lung cancer: Preliminary results of baseline screening. Chest 2003;124:614-621.
37. McMahon PM, Kong CY, Bouzan C et al. Costeffectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011;6:1841-1848.
38. Wood DE. Maximizing the benefit and minimizing the risks of lung cancer screening. J Thorac Imaging 2012;27:211-212.
39. Wood DE, Eapen GA, Ettinger DS et al. Lung cancer screening. J Natl Compr Canc Netw 2012;10: 240-265.
40. Rosen MP, Corey J, Siewert B. Establishing a computed tomography screening clinic. J Thorac Imaging 2012;27:220-223.
41. MacMahon H, Austin JH, Gamsu G et al. Guidelines for management of small pulmonary nodules detectedon CT scans:Astatement from the Fleischner Society. Radiology 2005;237:395-400.
42. Klabunde CN, Marcus PM, Han PK et al. Lung cancer screening practices of primary care physicians: Results from a national survey. Ann Fam Med 2012;10:102-110.
43. Croswell JM, Baker SG, Marcus PM et al. Cumulative incidence of false-positive test results in lung cancer screening: A randomized trial. Ann Intern Med 2010;152:505-512, W176-W180.
44. van den Bergh KA, Essink-Bot ML, Borsboom GJ et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010;102:27-34.
45. Wender R, Fontham ET, Barrera E Jr. et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-117.